William P. Forbes

Insider Reports History

Entity
Individual
Location
C/O Salix Pharmaceuticals, Ltd., 8510 Colonnade Center Drive, Raleigh, North Carolina
Signature
/s/ Kathryn Lester Attorney-in-Fact for William P. Forbes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William P. Forbes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Development Officer Common Stock 99.2K $262K $2.64 Jul 19, 2024 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Development Officer Restricted Stock Units 54.2K $143K $2.64 Jul 19, 2024 Direct
Beyond Air, Inc. Director Common Stock 14.9K $24.2K $1.63 Mar 31, 2023 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Development Officer Employee Stock Option (Right to Buy) 372K Jan 19, 2024 Direct
Trevi Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 138K Feb 11, 2022 Direct
Trevi Therapeutics, Inc. Chief Development Officer Performance Stock Options (right to buy) 48K Jun 29, 2022 Direct
Beyond Air, Inc. Director Stock Option (right to buy) 45K Mar 20, 2024 Direct

Insider Reports Filed by William P. Forbes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 19, 2024 2 $0 4 Jul 22, 2024 EVP, Chief Development Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 6, 2024 2 $0 4 Jun 7, 2024 EVP, Chief Development Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 19, 2024 2 $0 4 Apr 19, 2024 EVP, Chief Development Officer
XAIR Beyond Air, Inc. Mar 20, 2024 1 $0 4 Mar 21, 2024 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 19, 2024 2 $0 4 Jan 19, 2024 EVP, Chief Development Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Nov 17, 2023 1 $27.3K 4 Nov 21, 2023 EVP, Chief Development Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Nov 16, 2023 1 $47K 4 Nov 20, 2023 EVP, Chief Development Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 6, 2023 0 $0 3 Jun 12, 2023 EVP, Chief Development Officer
XAIR Beyond Air, Inc. Mar 31, 2023 1 $33.4K 4 Apr 3, 2023 Director
XAIR Beyond Air, Inc. Mar 29, 2023 1 $0 4 Mar 31, 2023 Director
XAIR Beyond Air, Inc. Mar 17, 2023 1 $32.3K 4 Mar 20, 2023 Director
TRVI Trevi Therapeutics, Inc. Jun 29, 2022 1 $0 4 Jul 1, 2022 Chief Development Officer
XAIR Beyond Air, Inc. Mar 3, 2022 1 $0 4 Mar 7, 2022 Director
TRVI Trevi Therapeutics, Inc. Feb 11, 2022 1 $0 4/A Jul 1, 2022 Chief Development Officer